| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.28 | 0.07 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.08 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.07 | 0.09 |